4DX 2.86% 54.0¢ 4dmedical limited

Research, page-2586

  1. 2,165 Posts.
    lightbulb Created with Sketch. 614
    I see 4DMedical’s X-ray Velocimetry for Bronchoscopic Lung Volume Reduction Targeting clincial trial has finally completed. Wonder if we’ll get an update or if the results are locked.

    NCT04786171 – Completed

    This study will investigate the utility of 4D Medical's X-ray Velocimetry (XV) imaging analysis software for the detection of hyperinflation, and compare endobronchial valve placement outcomes with predictive indices obtained utilizing this technique.

    Sponsor
    Vanderbilt University Medical Center  
    Collaborators
    American Thoracic Society

    Conditions   
    • Copd
    • Emphysema
    • Hyperinflation

    Study Start (Actual)
    2021-01-07
    Primary Completion (Actual)
    2024-05-30
    Study Completion (Actual)
    2024-05-30
    Last Update
    2024-06-18
    Enrollment (Actual)
    17

    Study Population
    Adults with symptomatic emphysema with hyperinflation and no conflating lung diseases or pregnancy.

    Inclusion:
    CT chest and PFTs within the last two years
    Age over 18
    COPD with emphysema
    Global Initiative for Chronic Obstructive Lung Disease (GOLD) 3 - 4 classification OR modified Medical Research Council (mMRC) score of 2 or greater.

    Exclusion Criteria:
    Pregnancy
    Presence of an additional pulmonary disease beyond COPD
    Inability to raise arms above 90 degrees as required for fluoroscopy

    They wanted a cohort of 50, yet with the tight parameters only managed 17.
 
watchlist Created with Sketch. Add 4DX (ASX) to my watchlist
(20min delay)
Last
54.0¢
Change
0.015(2.86%)
Mkt cap ! $215.5M
Open High Low Value Volume
53.0¢ 54.0¢ 51.5¢ $226.9K 431.3K

Buyers (Bids)

No. Vol. Price($)
1 16886 54.0¢
 

Sellers (Offers)

Price($) Vol. No.
54.5¢ 41547 4
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
4DX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.